Detailed Agenda

Please continue to check this page for additional information 

Click here to download a PDF of the agenda. 


Tuesday, November 7

12:00 - 12:30 pm: Welcome and Opening Remarks

  • Eric Schultz, MBA, President and CEO, Harvard Pilgrim Health Care
  • Alan Garber, MD, PhD, Provost, Harvard University; Mallinckrodt Professor of Health Care Policy, Harvard Medical School; Professor of Economics, Faculty of Arts and Sciences; Professor of Public Policy, Harvard Kennedy School of Government; Professor, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health
  • Thomas S. Inui, ScM, MD, MACP,  Founding Chair, Department of Ambulatory Care and Prevention (now DPM)


12:30 - 1:00 pm: State of the DPM

  • Richard Platt, MD, MSc, Professor and Chair, Department of Population Medicine; Executive Director, Harvard Pilgrim Health Care Institute 


1:00 - 2:00 pm: Panel Session: Obesity and Diabetes
Rates of diabetes have doubled in the US in the last 30 years.  Obesity continues to climb in most populations, contributing to the higher rates of diabetes and other cardiovascular conditions.  DPM investigators and alumni have led a breadth of epidemiologic, intervention and health services research studies into the causes, sequelae, and prevention of obesity, diabetes, and related chronic disease risk, with a focus on defined populations.  This session will focus on how DPM’s research on this topic has changed policy and practice, and the challenges and opportunities that lie ahead for obesity and diabetes prevention and care.

  • Matthew Gillman, MD, SM, Program Director, Environmental Influences on Child Health Outcomes (ECHO), National Institutes of Health
  • Elsie Taveras, MD, MPH, Chief, Division of General Pediatrics, Director, Pediatric Population Health Management, Director, Raising Healthy Hearts Clinic, MassGeneral Hospital for Children; Professor, Pediatrics, Harvard Medical School
  • Edward Gregg, PhD, MS, Chief, Epidemiology and Statistics Branch, Division of Diabetes Translation, Centers for Disease Control and Prevention
     

2:00 - 2:15 pm: Break


2:15 - 2:45 pm: Education Session

  • Gordon Moore, MD, MPH, Professor, Department of Population Medicine


2:45 - 3:45 pm: Panel Session: Lessons for the Future from Twenty-Five Years of Health Insurance Policy Research
DPM has been closely involved in research to understand the impact of evolving health insurance policies and the complex interactions between key stakeholders in the US health system. DPM research about health insurance policy over the last 25 years has focused on drug policy, provider reimbursement arrangements, Medicare, health reform, and new insurance benefit designs such as high-deductible plans.  Many important questions remain with the US health care system currently at a crucial crossroads.   Panelists in this session will reflect on past, current, and future issues in health insurance policy, including key issues and challenges for the future.

  • Joseph Newhouse, PhD, John D. MacArthur Professor of Health Policy and Management, Harvard University; Director, Division of Health Policy Research and Education, Harvard University; Director, Interfaculty Initiative on Health Policy, Harvard University
  • Carol Mangione, MD, MSPH, FACP, Chief, Division of General Medicine and Health Services Research, Barbara A. Levey & Gerald S. Levey Professor of Medicine and Public Health, University of California, Los Angeles
     

4:00 - 6:00 pm: Reception at Fenway Park 

  • Dell EMC Club, Fenway Park, RSVP required

Wednesday, November 8

8:00 am - 8:30 am: Opening Remarks Day 2

  • Jonathan Perlin, MD, PhD, MSHA, MACP, FACMI, President, Clinical Services, Chief Medical Officer, Hospital Corporation of America
  • Harvard Medical School leadership


8:30 am - 9:30 am: Thomas S. Inui Keynote Speaker

  • Tracy A. Lieu, MD, MPH, Director, Division of Research, Kaiser Permanente Northern California

 

9:30 - 10:30 am: Panel Session: Healthcare Associated Infections
DPM has partnered with healthcare delivery systems and public health to lead wide-ranging programs to create robust platforms for surveillance of healthcare associated infections in communities and in hospitals, develop novel quality measures targeting complications associated with hospitalization, implement large-scale interventions to prevent infections in healthcare settings, and evaluate the impact of payment policies on healthcare-associated infections.  Panelists in this session will look ahead to identify future research, policy, and implementation priorities in the field of healthcare-associated infections, and to identify targets that can measure the impact of work on this field.

  • John Jernigan, MD, MS, Director, Office of Prevention Research and Evaluation, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention;  Clinical Associate Professor, Division of Infectious Diseases, Emory University School of Medicine 
  • Kenneth Sands, MD, MPH, Chief Epidemiologist, Chief Patient Safety Officer, Hospital Corporation of America

 

10:30 - 10:45 am: Break

 

10:45 - 11:45 am: Panel Session: Surveillance 
DPM investigators have developed scientific, technical, and collaborative approaches that give public health agencies access to sophisticated surveillance capabilities for monitoring the health of populations.  Panelists in this session will discuss state, local, and national surveillance systems, focusing on progress that's been made and the future of the field.

  • Alfred DeMaria, MD, Medical Director, Bureau of Infectious Disease, Massachusetts Department of Public Health
  • Rachel Sherman, MD, MPH, Deputy Commissioner for Medical Products and Tobacco, Office of the Commissioner, Food and Drug Administration

 

11:45 am - 12:00 pm: Wrap-up and Closing Remarks